{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:00:59Z","timestamp":1747166459743,"version":"3.40.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jvacx.2024.100521","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T17:19:05Z","timestamp":1720113545000},"page":"100521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A cost benefit analysis of varicella vaccination in South Korea"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2073-993X","authenticated-orcid":false,"given":"Young Hwa","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2733-0715","authenticated-orcid":false,"given":"Young June","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2024.100521_b0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3345\/cep.2021.01564","article-title":"Global varicella vaccination programs","volume":"65","author":"Lee","year":"2022","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.jvacx.2024.100521_b0010","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvacx.2024.100521_b0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jvacx.2024.100521_b0020","doi-asserted-by":"crossref","first-page":"e1070","DOI":"10.1542\/peds.2005-2085","article-title":"One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?","volume":"117","author":"Lopez","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jvacx.2024.100521_b0025","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jvacx.2024.100521_b0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2016.02.040","article-title":"Strong additional effect of a second varicella vaccine dose in children in Germany, 2009\u20132014","volume":"173","author":"Siedler","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jvacx.2024.100521_b0035","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1016\/j.vaccine.2020.09.038","article-title":"Trend in varicella patients 4 years after implementation of universal two-dose varicella vaccination in Japan","volume":"38","author":"Hattori","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100521_b0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jama.1994.03510290057037","article-title":"Cost-effectiveness of a routine varicella vaccination program for US children","volume":"271","author":"Lieu","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jvacx.2024.100521_b0045","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14760584.7.6.753","article-title":"Cost-effectiveness of varicella vaccination programs: an update of the literature","volume":"7","author":"Rozenbaum","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"Suppl 2","key":"10.1016\/j.jvacx.2024.100521_b0050","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/522135","article-title":"An economic analysis of the universal varicella vaccination program in the United States","volume":"197","author":"Zhou","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100521_b0055","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/INF.0000000000003448","article-title":"Economic evaluation of universal varicella vaccination in Mexico","volume":"41","author":"Chacon-Cruz","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jvacx.2024.100521_b0060","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/CVI.00645-13","article-title":"Varicella and varicella vaccination in South Korea","volume":"21","author":"Oh","year":"2014","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.jvacx.2024.100521_b0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.24171\/j.phrp.2022.0087","article-title":"Epidemiological characteristics of varicella outbreaks in the Republic of Korea, 2016\u20132020","volume":"13","author":"Kim","year":"2022","journal-title":"Osong Public Health Res Perspect"},{"key":"10.1016\/j.jvacx.2024.100521_b0070","unstructured":"Jung Y-H. A Report of Korea Health Panel Survey 2008 (1): Korea Institute for Health and Social affairs; 2009."},{"key":"10.1016\/j.jvacx.2024.100521_b0075","unstructured":"ANNUAL REPORT ON THE ECONOMICALLY ACTIVE POPULATION SURVEY: Statistics Korea; 2023."},{"key":"10.1016\/j.jvacx.2024.100521_b0080","unstructured":"ANNUAL REPORT ON THE CONSUMER PRICE INDEX (2022): Statistics Korea; 2023."},{"key":"10.1016\/j.jvacx.2024.100521_b0085","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3346\/jkms.2016.31.12.1897","article-title":"Effectiveness of varicella vaccination program in preventing laboratory-confirmed cases in children in Seoul, Korea","volume":"31","author":"Lee","year":"2016","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jvacx.2024.100521_b0090","doi-asserted-by":"crossref","first-page":"e3617","DOI":"10.1093\/cid\/ciaa1708","article-title":"Epidemiological impact and cost-effectiveness of varicella vaccination strategies in the United Kingdom","volume":"73","author":"Akpo","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.jvacx.2024.100521_b0095","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3346\/jkms.2012.27.S.S13","article-title":"Trends in scale and structure of Korea's health expenditure over last three decades (1980\u20132009): financing, functions and providers","volume":"27","author":"Jeong","year":"2012","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jvacx.2024.100521_b0100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jmv.27434","article-title":"Spatiotemporal distribution of varicella in the Republic of Korea","volume":"94","author":"Lee","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.jvacx.2024.100521_b0105","first-page":"1","article-title":"Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jvacx.2024.100521_b0110","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/21645515.2015.1008880","article-title":"Trends in varicella mortality in the United States: data from vital statistics and the national surveillance system","volume":"11","author":"Leung","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jvacx.2024.100521_b0115","doi-asserted-by":"crossref","first-page":"S407","DOI":"10.1093\/infdis\/jiac242","article-title":"Decline in severe varicella disease during the United States varicella vaccination program: hospitalizations and deaths, 1990\u20132019","volume":"226","author":"Marin","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100521_b0120","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1093\/infdis\/jiac251","article-title":"25 years of varicella vaccination in the United States","volume":"226","author":"Marin","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100521_b0125","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/INF.0000000000003958","article-title":"The protective effectiveness of 2-dose varicella vaccination in children in Korea: a case-control study","volume":"42","author":"Lee","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jvacx.2024.100521_b0130","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.3346\/jkms.2021.36.e222","article-title":"Waning effectiveness of one-dose universal varicella vaccination in Korea, 2011\u20132018: a propensity score matched national population cohort","volume":"36","author":"Hong","year":"2021","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jvacx.2024.100521_b0135","doi-asserted-by":"crossref","first-page":"2085468","DOI":"10.1080\/21645515.2022.2085468","article-title":"Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling","volume":"18","author":"Suh","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jvacx.2024.100521_b0140","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1017\/S0950268814002441","article-title":"Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test","volume":"143","author":"Han","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jvacx.2024.100521_b0145","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.3346\/jkms.2019.34.e53","article-title":"Epidemiological impact of the Korean national immunization program on varicella incidence","volume":"34","author":"Jung","year":"2019","journal-title":"J Korean Med Sci"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T03:45:41Z","timestamp":1723520741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136224000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":29,"alternative-id":["S2590136224000949"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100521","relation":{},"ISSN":["2590-1362"],"issn-type":[{"type":"print","value":"2590-1362"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cost benefit analysis of varicella vaccination in South Korea","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100521"}}